CC BY-NC-ND 4.0 · Pneumologie 2024; 78(09): 634-648
DOI: 10.1055/a-2331-8978
Übersicht

Zehn Jahre Hypoglossusnerv-Stimulation bei obstruktiver Schlafapnoe – ein systematischer Literaturreview

Ten years of hypoglossal nerve stimulation in obstructive sleep apnea: a systematic literature review
Susanne Habetha
1   Healthcare Heads GmbH, Kiel, Deutschland
,
Sven Sauermann
1   Healthcare Heads GmbH, Kiel, Deutschland
,
Stefanie Müller
1   Healthcare Heads GmbH, Kiel, Deutschland
,
Gerd Gottschalk
2   GERD Consulting, Kreuzau, Deutschland
› Author Affiliations
Supported by: Nyxoah S.A., Mont-Saint-Guibert, Belgium Dieser Artikel wurde nicht öffentlich gefördert.

Zusammenfassung

Zielsetzung Es soll die Bedeutung der Hypoglossusnerv-Stimulation (HGNS) als Behandlungsmethode der obstruktiven Schlafapnoe (OSA) im deutschen Versorgungskontext dargestellt werden, um im Ergebnis eine bessere Einschätzung darüber zu erhalten, in welcher Weise Patienten, die bisher nicht ausreichend versorgt sind, von der HGNS profitieren können.

Methoden Anhand einer systematischen Literaturauswertung in den Literaturdatenbanken Medline und Cochrane Library, in die unterschiedliche Stimulationstechnologien eingeschlossen wurden, wurde die Wirksamkeit der HGNS mithilfe patientenrelevanter Endpunkte (Tagesschläfrigkeit, Lebensqualität), die Therapieadhärenz sowie der Apnoe-Hypopnoe-Index (AHI) und Oxygen Desaturation Index (ODI) eingeschätzt. Die Sicherheit der Behandlungsmethode wurde anhand der unerwünschten Ereignisse (UE) überprüft.

Ergebnisse Einschluss und Auswertung von 33 Publikationen: 2 randomisierte kontrollierte Studien (RCTs, Level Ib), 1 Studie Level IIb (n = 1) und 30 Studien Level IV mit einer Studiendauer von bis zu 60 Monaten. In den RCTs zeigten sich für die Tagesschläfrigkeit und Lebensqualität unter Anwendung der HGNS bessere Werte als in der Kontrollgruppe. AHI und ODI wiesen unter Placebostimulation bzw. Therapieentzug in den RCTs eine Verschlechterung auf. Zur Adhärenz wurden auch im Langzeitverlauf konsistent hohe Werte berichtet. Schwere UE unter HGNS waren selten und konnten meist durch eine Repositionierung von Elektroden oder einen Austausch von Geräteteilen beseitigt werden. Andere UE waren überwiegend vorübergehend oder konnten durch nicht-invasive Maßnahmen behoben werden. Alle untersuchten Parameter zeigten gleichgerichtete Ergebnisse in den ausgewerteten Studien. Die Ergebnisse von unterschiedlichen Stimulationssystemen sind in Art und Ausmaß vergleichbar.

Schlussfolgerung Basierend auf einer umfangreichen Literaturauswertung unterstreichen konsistente Daten die Bedeutung der HGNS als wirksame und sichere Behandlung der OSA nach erfolgloser CPAP-Behandlung. Die Auswertung lässt darüber hinaus erkennen, dass die unterschiedlichen Stimulationssysteme eine an den patientenindividuellen Erfordernissen ausgerichtete Therapie ermöglichen. Eine zukünftige systematische Auswertung von Real-World-Daten zur Anwendung der HGNS erscheint notwendig, um zusätzliche Erkenntnisse über die Relevanz der Methode in der klinischen Routine zu erhalten.

Abstract

Objective To show the importance of hypoglossal nerve stimulation (HGNS) as a treatment method for obstructive sleep apnea (OSA) in the German healthcare context and to better assess the way patients who do not receive adequate care could benefit from HGNS.

Methods A systematic literature review in the Medline and Cochrane Library literature database was conducted, including publications using different stimulation technologies for HGNS. The efficacy of HGNS was assessed based on patient-relevant outcomes (daytime sleepiness, quality of life), treatment adherence and the apnea-hypopnea index (AHI) and oxygen desaturation index (ODI). The safety of the treatment method was assessed based on adverse events (AEs).

Results Inclusion and analysis of 33 publications: 2 randomized controlled trials (RCTs, level Ib), 1 level IIb trial (n = 1) and 30 level IV trials with a study duration of up to 60 months. The RCTs showed better values for daytime sleepiness and quality of life when using HGNS than in the control group. AHI and ODI showed a deterioration under placebo stimulation or therapy withdrawal in the RCTs. Consistently high adherence was also reported in the long-term course. Severe AEs under HGNS were rare and could usually be resolved by repositioning electrodes or replacing device components. Other AEs were mostly transient or could be resolved by non-invasive measures. All investigated parameters showed similar results in the evaluated studies. The results of different stimulation systems are comparable in type and extent.

Conclusion The comprehensive review of the literature shows consistent data that highlight the importance of HGNS as an effective and safe treatment for OSA after unsuccessful CPAP treatment. The evaluation also shows that the different stimulation systems make it possible to better tailor the therapy to the patientʼs individual requirements. A future systematic evaluation of real-world data on the use of HGNS would help gain additional insights into the relevance of the method in routine clinical practice.



Publication History

Received: 18 January 2024

Accepted after revision: 05 May 2024

Article published online:
24 June 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • Literatur

  • 1 Heiser C, Hofauer B. Stimulation bei Schlafapnoe: Stimulation des Nervus hypoglossus zur Behandlung der OSA. HNO 2018; 66: 705-716
  • 2 Deutsche Gesellschaft für Schlafforschung und Schlafmedizin (DGSM). Teil-Aktualisierung S3-Leitlinie Schlafbezogene Atmungsstörungen bei Erwachsenen. AWMF online 2020. Accessed October 10, 2021 at: https://www.awmf.org/fileadmin/user_upload/Leitlinien/063_D_Ges_fuer_Schlafforschung_und_Schlafmedizin/063–001l_S3_SBAS_Teil-Aktualisierung_2020_2020–09.pdf
  • 3 Franklin KA, Lindberg E. Obstructive sleep apnea is a common disorder in the population-a review on the epidemiology of sleep apnea. J Thorac Dis 2015; 7: 1311-1322
  • 4 Benjafield AV, Ayas NT, Eastwood PR. et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med 2019; 7: 687-698
  • 5 Lee W, Nagubadi S, Kryger MH. et al. Epidemiology of Obstructive Sleep Apnea: a Population-based Perspective. Expert Rev Respir Med 2008; 2: 349-364
  • 6 Xia F, Sawan M. Clinical and Research Solutions to Manage Obstructive Sleep Apnea: A Review. Sensors (Basel) 2021; 21
  • 7 Patil SP, Ayappa IA, Caples SM. et al. Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 2019; 15: 335-343
  • 8 Caples SM, Rowley JA, Prinsell JR. et al. Surgical modifications of the upper airway for obstructive sleep apnea in adults: a systematic review and meta-analysis. Sleep 2010; 33: 1396-1407
  • 9 Deutsche Gesellschaft für Schlafforschung und Schlafmedizin (DGSM). S3-Leitlinie Nicht erholsamer Schlaf/Schlafstörung Kapitel „Schlafbezogene Atmungsstörungen bei Erwachsenen“. AWMF online. 2017 Accessed -1 -1, 202 at: https://www.awmf.org/uploads/tx_szleitlinien/063-001l_S3_SBAS_2017-08_2_verlaengert_und_Hinweis_Teil-Aktualisierung_2020-07.pdf
  • 10 Sunwoo BY, Light M, Malhotra A. Strategies to augment adherence in the management of sleep-disordered breathing. Respirology 2020; 25: 363-371
  • 11 Sawyer AM, Gooneratne NS, Marcus CL. et al. A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions. Sleep Med Rev 2011; 15: 343-356
  • 12 Weaver TE. Novel Aspects of CPAP Treatment and Interventions to Improve CPAP Adherence. J Clin Med 2019; 8
  • 13 Dedhia RC, Strollo PJ, Soose RJ. Upper Airway Stimulation for Obstructive Sleep Apnea: Past, Present, and Future. Sleep 2015; 38: 899-906
  • 14 Malhotra A. Hypoglossal-nerve stimulation for obstructive sleep apnea. N Engl J Med 2014; 370: 170-171
  • 15 Orr JE, Ishman SL, Sarmiento KF. Stimulating Progress in the Upper Airway. Sleep 2015; 38: 851-852
  • 16 Zhu Z, Hofauer B, Wirth M. et al. Long-term changes of stimulation intensities in hypoglossal nerve stimulation. J Clin Sleep Med 2020; 16: 1775-1780
  • 17 Woodson BT. Reply on „Upper Airway Stimulation for Obstructive Sleep Apnea: 5-Year Outcomes“. Official Journal of American Academy of Otolaryngology – Head and Neck Surgery 2018; 159: 806
  • 18 Steffen A, Sommer UJ, Maurer JT. et al. Long-term follow-up of the German post-market study for upper airway stimulation for obstructive sleep apnea. Sleep Breath 2020; 24: 979-984
  • 19 Arens P, Penzel T, Fietze I. et al. Safety and effectiveness in explantation and re-implantation of hypoglossal nerve stimulation devices. Eur Arch Otorhinolaryngol 2021; 278: 477-483
  • 20 Schwartz AR, Smith PL, Oliven A. Electrical stimulation of the hypoglossal nerve: a potential therapy. J Appl Physiol (1985) 2014; 116: 337-344
  • 21 Schwartz AR, Eisele DW, Hari A. et al. Electrical stimulation of the lingual musculature in obstructive sleep apnea. J Appl Physiol (1985) 1996; 81: 643-652
  • 22 Heiser C, Hofauer B. Hypoglossusnervstimulation bei CPAP-Versagen: Evolution einer Alternativbehandlung für Patienten mit obstruktiver Schlafapnoe. HNO 2017; 65: 99-106
  • 23 Strollo PJJ, Gillespie MB, Soose RJ. et al. Upper Airway Stimulation for Obstructive Sleep Apnea: Durability of the Treatment Effect at 18 Months. Sleep 2015; 38: 1593-1598
  • 24 Van de Heyning PH, Badr MS, Baskin JZ. et al. Implanted upper airway stimulation device for obstructive sleep apnea. Laryngoscope 2012; 122: 1626-1633
  • 25 Mwenge GB, Rombaux P, Dury M. et al. Targeted hypoglossal neurostimulation for obstructive sleep apnoea: a 1-year pilot study. Eur Respir J 2013; 41: 360-367
  • 26 Nyxoah. Das GenioTM-System Gebrauchsanweisung für Schlaflabore. 2019
  • 27 Mashaqi S, Patel SI, Combs D. et al. The Hypoglossal Nerve Stimulation as a Novel Therapy for Treating Obstructive Sleep Apnea – A Literature Review. Int J Environ Res Public Health 2021; 18
  • 28 Heiser C, Hofauer B. Hypoglossusnervstimulation bei CPAP-Versagen: Evolution einer Alternativbehandlung für Patienten mit obstruktiver Schlafapnoe. HNO 2017; 65: 99-106
  • 29 Inspire Medical Systems. Inspire Therapie bei obstruktiver Schlafapnoe. 2021
  • 30 Braun M, Stoerzel M, Wollny M. et al. Patient-reported outcomes with hypoglossal nerve stimulation for treatment of obstructive sleep apnea: a systematic review and meta-analysis. European Archives of Oto-Rhino-Laryngology 2023; 280: 4627-4639
  • 31 Gemeinsamer Bundesausschuss. Beschluss des Gemeinsamen Bundesausschusses gemäß 2. Kapitel § 38 Absatz 2 Satz 1 der Verfahrensordnung: Stimulation des Nervus hypoglossus durch ein teilimplantierbares Stimulationssystem bei obstruktiver Schlafapnoe. 2020
  • 32 Gemeinsamer Bundesausschuss. Tragende Gründe zum Beschluss des Gemeinsamen Bundesausschusses gemäß 2. Kapitel § 38 Absatz 2 Satz 1 der Verfahrensordnung: Stimulation des Nervus hypoglossus durch ein teilimplantierbares Stimulationssystem bei obstruktiver Schlafapnoe. 2020
  • 33 Steffen A, Heiser C, Galetke W. et al. Die Stimulation des Nervus hypoglossus in der Behandlung der obstruktiven Schlafapnoe. Aktualisiertes Positionspapier der Arbeitsgemeinschaft Schlafmedizin der DGHNO-KHC. Laryngorhinootologie 2021; 100: 15-20
  • 34 Manual Systematische Recherche für Evidenzsynthesen und Leitlinien. Version 2.1. (14.12.2020). Freiburg: Cochrane Deutschland Stiftung, Institut für Evidenz in der Medizin, Institut für Medizinische Biometrie und Statistik; 2020
  • 35 Page MJ, McKenzie JE, Bossuyt PM. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71
  • 36 Gemeinsamer Bundesausschusses. Verfahrensordnung des Gemeinsamen Bundesausschusses. 2021
  • 37 CEBM. Oxford Centre for Evidence-based Medicine – Levels of Evidence (March 2009). Centre for Evidence-based Medicine (CEBM) 2021. Accessed November 30, 2021 at: https://www.cebm.ox.ac.uk/resources/levels-of-evidence/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009
  • 38 IQWIG (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen). Unterkieferprotrusionsschiene bei leichter bis mittelgradiger obstruktiver Schlafapnoe bei Erwachsenen. Abschlussbericht. 2020
  • 39 Johns M. Epworth Sleepiness Scale (ESS). Accessed November 20, 2021 at: https://epworthsleepinessscale.com/about-the-ess/
  • 40 Patel S, Kon SSC, Nolan CM. et al. The Epworth Sleepiness Scale: Minimum Clinically Important Difference in Obstructive Sleep Apnea. Am J Respir Crit Care Med 2018; 197: 961-963
  • 41 Crook S, Sievi NA, Bloch KE. et al. Minimum important difference of the Epworth Sleepiness Scale in obstructive sleep apnoea: estimation from three randomised controlled trials. Thorax 2019; 74: 390-396
  • 42 Weaver TE, Laizner AM, Evans LK. et al. An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep 1997; 20: 835-843
  • 43 Weaver TE, Maislin G, Dinges DF. et al. Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep 2007; 30: 711-719
  • 44 American Academy of Sleep Medicine. The International Classification of Sleep Disorders, Third Edition (ICSD-3). American Academy of Sleep Medicine; 2014.
  • 45 Heiser C, Steffen A, Hofauer B. et al. Effect of Upper Airway Stimulation in Patients with Obstructive Sleep Apnea (EFFECT): A Randomized Controlled Crossover Trial. J Clin Med 2021; 10
  • 46 Woodson BT, Gillespie MB, Soose RJ. et al. Randomized controlled withdrawal study of upper airway stimulation on OSA: short- and long-term effect. Official Journal of American Academy of Otolaryngology – Head and Neck Surgery 2014; 151: 880-887
  • 47 Mehra R, Steffen A, Heiser C. et al. Upper Airway Stimulation versus Untreated Comparators in Positive Airway Pressure Treatment-Refractory Obstructive Sleep Apnea. Ann Am Thorac Soc 2020; 17: 1610-1619
  • 48 Hofauer B, Philip P, Wirth M. et al. Effects of upper-airway stimulation on sleep architecture in patients with obstructive sleep apnea. Sleep Breath 2017; 21: 901-908
  • 49 Heiser C, Maurer JT, Hofauer B. et al. Outcomes of Upper Airway Stimulation for Obstructive Sleep Apnea in a Multicenter German Postmarket Study. Official journal of American Academy of Otolaryngology – Head and Neck Surgery 2017; 156: 378-384
  • 50 Gillespie MB, Soose RJ, Woodson BT. et al. Upper Airway Stimulation for Obstructive Sleep Apnea: Patient-Reported Outcomes after 48 Months of Follow-up. Official Journal of American Academy of Otolaryngology – Head and Neck Surgery 2017; 156: 765-771
  • 51 Strollo PJJ, Soose RJ, Maurer JT. et al. Upper-airway stimulation for obstructive sleep apnea. N Engl J Med 2014; 370: 139-149
  • 52 Woodson BT, Soose RJ, Gillespie MB. et al. Three-Year Outcomes of Cranial Nerve Stimulation for Obstructive Sleep Apnea: The STAR Trial. Otolaryngol Head Neck Surg 2016; 154: 181-188
  • 53 Heiser C, Knopf A, Bas M. et al. Selective upper airway stimulation for obstructive sleep apnea: a single center clinical experience. Eur Arch Otorhinolaryngol 2017; 274: 1727-1734
  • 54 Bohorquez D, Mahmoud AF, Yu JL. et al. Upper airway stimulation therapy and sleep architecture in patients with obstructive sleep apnea. Laryngoscope 2020; 130: 1085-1089
  • 55 Huntley C, Kaffenberger T, Doghramji K. et al. Upper Airway Stimulation for Treatment of Obstructive Sleep Apnea: An Evaluation and Comparison of Outcomes at Two Academic Centers. J Clin Sleep Med 2017; 13: 1075-1079
  • 56 Vonk PE, Ravesloot MJL, van Maanen JP. et al. Short-term results of upper airway stimulation in obstructive sleep apnoea patients: the Amsterdam experience. J Laryngol Otol 2020; 134: 447-452
  • 57 Friedman M, Jacobowitz O, Hwang MS. et al. Targeted hypoglossal nerve stimulation for the treatment of obstructive sleep apnea: Six-month results. Laryngoscope 2016; 126: 2618-2623
  • 58 Weeks B, Bao G, Gilbert TM. et al. Hypoglossal Nerve Stimulator Implantation in a Non-Academic Setting: Two-Year Result. Laryngoscope Investig Otolaryngol 2018; 3: 315-318
  • 59 Coca KK, Heiser C, Huntley C. et al. Hypoglossal Nerve Stimulation Usage by Therapy Nonresponders. Otolaryngol Head Neck Surg 2022; 166: 786-790
  • 60 Boon M, Huntley C, Steffen A. et al. Upper Airway Stimulation for Obstructive Sleep Apnea: Results from the ADHERE Registry. Official Journal of American Academy of Otolaryngology – Head and Neck Surgery 2018; 159: 379-385
  • 61 Thaler E, Schwab R, Maurer J. et al. Results of the ADHERE upper airway stimulation registry and predictors of therapy efficacy. Laryngoscope 2020; 130: 1333-1338
  • 62 Hasselbacher K, Hofauer B, Maurer JT. et al. Patient-reported outcome: results of the multicenter German post-market study. Eur Arch Otorhinolaryngol 2018; 275: 1913-1919
  • 63 Hofauer B, Steffen A, Knopf A. et al. Patient experience with upper airway stimulation in the treatment of obstructive sleep apnea. Sleep Breath 2019; 23: 235-241
  • 64 Steffen A, Sommer JU, Hofauer B. et al. Outcome after one year of upper airway stimulation for obstructive sleep apnea in a multicenter German post-market study. Laryngoscope 2018; 128: 509-515
  • 65 Soose RJ, Woodson BT, Gillespie MB. et al. Upper Airway Stimulation for Obstructive Sleep Apnea: Self-Reported Outcomes at 24 Months. J Clin Sleep Med 2016; 12: 43-48
  • 66 Woodson BT, Strohl KP, Soose RJ. et al. Upper Airway Stimulation for Obstructive Sleep Apnea: 5-Year Outcomes. Official Journal of American Academy of Otolaryngology – Head and Neck Surgery 2018; 159: 194-202
  • 67 Eastwood PR, Barnes M, Walsh JH. et al. Treating obstructive sleep apnea with hypoglossal nerve stimulation. Sleep 2011; 34: 1479-1486
  • 68 Eastwood PR, Barnes M, MacKay SG. et al. Bilateral hypoglossal nerve stimulation for treatment of adult obstructive sleep apnoea. Eur Respir J 2020; 55: 1901320
  • 69 Kezirian EJ, Goding GSJ, Malhotra A. et al. Hypoglossal nerve stimulation improves obstructive sleep apnea: 12-month outcomes. J Sleep Res 2014; 23: 77-83
  • 70 Certal VF, Zaghi S, Riaz M. et al. Hypoglossal nerve stimulation in the treatment of obstructive sleep apnea: A systematic review and meta-analysis. Laryngoscope 2015; 125: 1254-1264
  • 71 Costantino A, Rinaldi V, Moffa A. et al. Hypoglossal nerve stimulation long-term clinical outcomes: a systematic review and meta-analysis. Sleep Breath 2020; 24: 399-411
  • 72 Kompelli AR, Ni JS, Nguyen SA. et al. The outcomes of hypoglossal nerve stimulation in the management of OSA: A systematic review and meta-analysis. World J Otorhinolaryngol Head Neck Surg 2019; 5: 41-48
  • 73 Bestourous DE, Pasick LJ, Benito DA. et al. Adverse events associated with the Inspire implantable hypoglossal nerve stimulator: A MAUDE database review. Am J Otolaryngol 2020; 41: 102616
  • 74 Bellamkonda N, Shiba T, Mendelsohn AH. Adverse Events in Hypoglossal Nerve Stimulator Implantation: 5-Year Analysis of the FDA MAUDE Database. Official Journal of American Academy of Otolaryngology – Head and Neck Surgery 2021; 164: 443-447
  • 75 Sher AE, Schechtman KB, Piccirillo JF. The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome. Sleep 1996; 19: 156-177
  • 76 Franklin KA, Anttila H, Axelsson S. et al. Effects and side-effects of surgery for snoring and obstructive sleep apnea – a systematic review. Sleep 2009; 32: 27-36
  • 77 Halle TR, Oh MS, Collop NA. et al. Surgical Treatment of OSA on Cardiovascular Outcomes: A Systematic Review. Chest 2017; 152: 1214-1229
  • 78 Smith DF, Cohen AP, Ishman SL. Surgical management of OSA in adults. Chest 2015; 147: 1681-1690
  • 79 Whelan R, Soose RJ. Implantable Neurostimulation for Treatment of Sleep Apnea: Present and Future. Otolaryngol Clin North Am 2020; 53: 445-457
  • 80 Baptista PM, Costantino A, Moffa A. et al. Hypoglossal Nerve Stimulation in the Treatment of Obstructive Sleep Apnea: Patient Selection and New Perspectives. Nat Sci Sleep 2020; 12: 151-159
  • 81 Vanderveken O, Beyers J, Beeck SO de. et al. Development of a Clinical Pathway and Technical Aspects of Upper Airway Stimulation Therapy for Obstructive Sleep Apnea. Front Neurosci 2017; 11: 523
  • 82 Yu JL, Thaler ER. Hypoglossal Nerve (Cranial Nerve XII) Stimulation. Otolaryngol Clin North Am 2020; 53: 157-169